1 | by the end of | | | | | | | 5 | 0.50% |
2 | yet by the end | | | | | | | 5 | 0.50% |
3 | the end of this | | | | | | | 4 | 0.40% |
4 | ratings yet by the | | | | | | | 4 | 0.40% |
5 | be able to 1 | | | | | | | 4 | 0.40% |
6 | no ratings yet by | | | | | | | 3 | 0.30% |
7 | 92 no ratings yet | | | | | | | 3 | 0.30% |
8 | issue 92 no ratings | | | | | | | 3 | 0.30% |
9 | hypertensive and presenting with | | | | | | | 3 | 0.30% |
10 | a patient who is | | | | | | | 3 | 0.30% |
11 | realistic lowcost simulated automated | | | | | | | 2 | 0.20% |
12 | treatment for a patient | | | | | | | 2 | 0.20% |
13 | a simulated scenario to | | | | | | | 2 | 0.20% |
14 | the hyoepiglottic ligament a | | | | | | | 2 | 0.20% |
15 | catheterization lab a simulated | | | | | | | 2 | 0.20% |
16 | lowcost simulated automated chest | | | | | | | 2 | 0.20% |
17 | without a catheterization lab | | | | | | | 2 | 0.20% |
18 | choose the appropriate treatment | | | | | | | 2 | 0.20% |
19 | the appropriate treatment for | | | | | | | 2 | 0.20% |
20 | patient who is hypertensive | | | | | | | 2 | 0.20% |
21 | for a patient who | | | | | | | 2 | 0.20% |
22 | emergency clinician recognition and | | | | | | | 2 | 0.20% |
23 | who is hypertensive and | | | | | | | 2 | 0.20% |
24 | is hypertensive and presenting | | | | | | | 2 | 0.20% |
25 | learners should be able | | | | | | | 2 | 0.20% |
26 | able to 1 recognize | | | | | | | 2 | 0.20% |
27 | and presenting with an | | | | | | | 2 | 0.20% |
28 | should be able to | | | | | | | 2 | 0.20% |
29 | simulated scenario to improve | | | | | | | 2 | 0.20% |
30 | a catheterization lab a | | | | | | | 2 | 0.20% |
31 | clinician recognition and execution | | | | | | | 2 | 0.20% |
32 | of the hyoepiglottic ligament | | | | | | | 2 | 0.20% |
33 | modification of an airway | | | | | | | 2 | 0.20% |
34 | st elevation myocardial infarction | | | | | | | 2 | 0.20% |
35 | training mannequin to teach | | | | | | | 2 | 0.20% |
36 | abortion complicated by disseminated | | | | | | | 2 | 0.20% |
37 | recognition and execution of | | | | | | | 2 | 0.20% |
38 | complicated by disseminated intravascular | | | | | | | 2 | 0.20% |
39 | by disseminated intravascular coagulation | | | | | | | 2 | 0.20% |
40 | engagement of the hyoepiglottic | | | | | | | 2 | 0.20% |